ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Talis Biomedical Corporation

Talis Biomedical Corporation (TLIS)

8.98
0.1101
(1.24%)
At close: August 06 4:00PM
3.70
-5.28
( -58.80% )
After Hours: 6:08PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.70
Bid
3.81
Ask
3.99
Volume
58,558
8.7083 Day's Range 9.35
4.35 52 Week Range 9.60
Market Cap
Previous Close
8.8699
Open
8.82
Last Trade
50
@
3.85
Last Trade Time
18:09:02
Financial Volume
$ 523,727
VWAP
8.9437
Average Volume (3m)
6,103
Shares Outstanding
1,822,153
Dividend Yield
-
PE Ratio
-0.26
Earnings Per Share (EPS)
-34.03
Revenue
2.13M
Net Profit
-62.01M

About Talis Biomedical Corporation

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious disease... Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Talis Biomedical Corporation is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TLIS. The last closing price for Talis Biomedical was $8.87. Over the last year, Talis Biomedical shares have traded in a share price range of $ 4.35 to $ 9.60.

Talis Biomedical currently has 1,822,153 shares outstanding. The market capitalization of Talis Biomedical is $16.16 million. Talis Biomedical has a price to earnings ratio (PE ratio) of -0.26.

TLIS Latest News

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash

REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery...

Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update

REDWOOD CITY, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery...

Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023

REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.76-56.26477541378.4698.475408.71812205CS
4-4.85-56.72514619888.5598.300151148.61170751CS
12-5.085-57.88275469558.7859.52998.2561038.76702376CS
26-3.43-48.10659186547.139.67.0177248.62035899CS
52-3.77-50.468540837.479.64.3597197.63241696CS
156-152-97.6236351959155.7155.9254.3510707936.47986296CS
260-431.3-99.1494252874435507.94.3513514890.18907697CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZCMDZhongchao Inc
$ 1.7509
(60.63%)
1.86M
SWIMLatham Group Inc
$ 3.98
(27.97%)
45.09k
STKHSteakholder Foods Ltd
$ 3.35
(24.07%)
331
INGNInogen Inc
$ 9.94
(21.96%)
23.52k
EMKREMCORE Corporation
$ 1.126
(19.04%)
363.93k
TLISTalis Biomedical Corporation
$ 3.70
(-58.80%)
40.15k
AACIArmada Acquisition Corporation I
$ 11.00
(-20.63%)
77.22k
CYRXCryoPort Inc
$ 6.35
(-18.49%)
118.44k
DZSIDZS Inc
$ 0.8601
(-17.30%)
61.62k
ABNBAirbnb Inc
$ 109.50
(-16.07%)
2.71M
NVDANVIDIA Corporation
$ 102.44
(-1.74%)
22.76M
SQQQProShares UltraPro Short QQQ
$ 10.66
(1.62%)
9.58M
GOOGLAlphabet Inc
$ 157.50
(-0.50%)
6.95M
INFNInfinera Corporation
$ 5.79
(0.00%)
6.94M
PRSTPresto Technologies Inc
$ 0.0293
(-5.48%)
6.61M

Discussion

View Full Feed
fsulevine fsulevine 3 minutes ago
I can’t figure out how to copy and paste a screenshot on here… works almost everywhere else. I’ld be glad to show my recent purchases of FCEL, now matter gow small they are.
FCEL
Mr Patience Mr Patience 3 minutes ago
This won’t take much to get going. Looking pretty thin.
BLEG
r-avilo r-avilo 4 minutes ago
No Glow says he guarantees, what an absurd statement.

No one can guarantee anything, in the stock markets, enough said, that should tell you all you need to know about this Clown,
Listen to him at your own peril..
WNFT Long and strong
WNFT
Chartmaster Chartmaster 4 minutes ago
#3 MOST POSTED BOARD!!!
ASII
PennyMillions852 PennyMillions852 4 minutes ago
Yet .0038 share price…..
IGPK
Here Today Here Today 4 minutes ago
Correct. Like I said earlier on another post, I meant 10,000 bottles. Still cvs not edit when using the app on IPhones.

But heck , I’d love to see a 100K bottle order for $10 million.
VDRM
gawti88 gawti88 5 minutes ago
haha like how he ignored my last post boys? ;)
CEOS
Chartmaster Chartmaster 5 minutes ago
#2 BREAKOUT BOARD!!!
ASII
QuantumTravesty QuantumTravesty 5 minutes ago
Run Forrest Run?
HIRU
slops slops 7 minutes ago
PantyPuller We have never been down this road
VDRM
valleybenedetto valleybenedetto 7 minutes ago
Sounds like a challenge. Accepted.
CLNV
Renee Renee 7 minutes ago
ADVZF: Pursuant to the Agreement, Silvercorp agreed to acquire all of the issued and outstanding common shares of Adventus. Under the Agreement, each Silvercorp shareholder, other than Silvercorp, received 0.1015 common shares of Silvercorp for each common share of Adventus held.

FINR
ADVZF
oystersnbeer oystersnbeer 8 minutes ago
In case you’re not watching the rally,
HARRIS / WALZ
HAVE ALREADY WON !!!
dstock07734 dstock07734 8 minutes ago
The next approval will be DCVax-L!

FDA approves vorasidenib for Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-vorasidenib-grade-2-astrocytoma-or-oligodendroglioma-sus
NWBO
SeaBlue SeaBlue 8 minutes ago
One has to wonder if Keith started buying again.
FFMGF
shajandr shajandr 9 minutes ago
Nope, the huge bolus of NP-1s is still stuck in the channel as the Best Buy sales associates have nott yett completed the NP-1 sales training.

In other NTEK news, DaFoleyFelon-Coyote remains steadfastly seated on bus to Federal prison. October cannot come fast enuff.
NTEK
SeaBlue SeaBlue 9 minutes ago
https://nexgold.com/nexgold-mining-and-wabigoon-lake-ojibway-nation-sign-new-relationship-agreement-for-goliath-gold-complex/
FFMGF
price_and_volume price_and_volume 9 minutes ago
"12 salesmen" working hard I'm sure. Lol.

OTCM still suggests "shell risk".

Using AI to build a website, write pump-tweets & create a massive share-marketing campaign aren't the same as running an operational business.

Seems like JK is a big fan of Honest
VXIT
joe botts joe botts 9 minutes ago
We need a real bear basher on this board and instead we got ....... You?
delerious1 delerious1 9 minutes ago
To D4 from D1....I'm loving it all,,,,don't need much to make a bundle
MJNA
ilovetolose1 ilovetolose1 10 minutes ago
https://investor.windstream.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=17707740

lookup keywords “Old Holdings” - lmk what you think when you can!
AtlasQ AtlasQ 10 minutes ago
Less is More.

Yesterday was so nice here, less jabber jibber even with the whole world going nuts. Why is it that bashing increases when the stock rises? Hmmmmmm

Something to think about.

Less is more.

Going back to my cave
RDGL
gorbec1 gorbec1 10 minutes ago
I small pps burning past old mcic highs
MCIC
slops slops 11 minutes ago
100,000 units at $100 per bottle = cool 10 mill $
VDRM
tat4tat tat4tat 11 minutes ago
Unpaid longs bring nothing to this board but guessing games. The CEO is their surrogate mommy dearest.
CEOS

Your Recent History

Delayed Upgrade Clock